Fineline Cube

Follow:
14389 Articles
Pfizer Launches Migraine Management Zone at China Pharmacy
CompanyDeals

Pfizer Launches Migraine Management Zone at China Pharmacy

CompanyDrug

Shouyao’s SY-9453 MAT2A Inhibitor Gets NMPA Nod for MTAP-Deleted Tumors

Innovent Biologics Revenue Surges 45% on Oncology Portfolio Expansion
Company

Innovent Biologics Revenue Surges 45% on Oncology Portfolio Expansion

CompanyDrug

Huadong Medicine DR10624 Gets NMPA Nod for Hypertriglyceridemia Study

CompanyDeals

Takeda Ends $128M Kyoto University iPSC Project After Decade of Research

HospitalPolicy / Regulatory

Beijing Online Consultation Pilot Gets NHC Approval for Children’s Care

AstraZeneca Saphnelo Faces FDA Setback with Complete Response Letter
CompanyDrug

AstraZeneca Saphnelo Faces FDA Setback with Complete Response Letter

AbbVie Immunology Portfolio Drives $61.2B Revenue in 2025
Company

AbbVie Immunology Portfolio Drives $61.2B Revenue in 2025

CompanyDeals

Mirxes Partners with XtalPi and Signet on AI-Driven Gastric Cancer System

Lishan Biopharma Licenses Evogene’s LS-LBP-002 for Global Oncology Development
CompanyDeals

Lishan Biopharma Licenses Evogene’s LS-LBP-002 for Global Oncology Development

Pfizer Revenue Drops 2% to $62.6B Amid COVID Decline, Non-COVID Portfolio Grows
Company

Pfizer Revenue Drops 2% to $62.6B Amid COVID Decline, Non-COVID Portfolio Grows

Merck Keytruda Revenue Drives $65.5B Sales Despite Gardasil China Slump
Others

Merck Keytruda Revenue Drives $65.5B Sales Despite Gardasil China Slump